Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Chronic Obstructive Pulmonary Disorder Market Size Growth Rate by Type (2014-2025) 1.4.2 Short-Acting Bronchodilators 1.4.3 Corticosteroids 1.4.4 Methylxanthines 1.4.5 Long-Acting Bronchodilators 1.4.6 Phosphodiesterase-4 Inhibitors 1.4.7 Others 1.5 Market by Application 1.5.1 Global Chronic Obstructive Pulmonary Disorder Market Share by Application (2014-2025) 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Chronic Obstructive Pulmonary Disorder Market Size 2.2 Chronic Obstructive Pulmonary Disorder Growth Trends by Regions 2.2.1 Chronic Obstructive Pulmonary Disorder Market Size by Regions (2014-2025) 2.2.2 Chronic Obstructive Pulmonary Disorder Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Chronic Obstructive Pulmonary Disorder Market Size by Manufacturers 3.1.1 Global Chronic Obstructive Pulmonary Disorder Revenue by Manufacturers (2014-2019) 3.1.2 Global Chronic Obstructive Pulmonary Disorder Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Chronic Obstructive Pulmonary Disorder Market Concentration Ratio (CR5 and HHI) 3.2 Chronic Obstructive Pulmonary Disorder Key Players Head office and Area Served 3.3 Key Players Chronic Obstructive Pulmonary Disorder Product/Solution/Service 3.4 Date of Enter into Chronic Obstructive Pulmonary Disorder Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Chronic Obstructive Pulmonary Disorder Market Size by Type (2014-2019) 4.2 Global Chronic Obstructive Pulmonary Disorder Market Size by Application (2014-2019) 5 United States 5.1 United States Chronic Obstructive Pulmonary Disorder Market Size (2014-2019) 5.2 Chronic Obstructive Pulmonary Disorder Key Players in United States 5.3 United States Chronic Obstructive Pulmonary Disorder Market Size by Type 5.4 United States Chronic Obstructive Pulmonary Disorder Market Size by Application 6 Europe 6.1 Europe Chronic Obstructive Pulmonary Disorder Market Size (2014-2019) 6.2 Chronic Obstructive Pulmonary Disorder Key Players in Europe 6.3 Europe Chronic Obstructive Pulmonary Disorder Market Size by Type 6.4 Europe Chronic Obstructive Pulmonary Disorder Market Size by Application 7 China 7.1 China Chronic Obstructive Pulmonary Disorder Market Size (2014-2019) 7.2 Chronic Obstructive Pulmonary Disorder Key Players in China 7.3 China Chronic Obstructive Pulmonary Disorder Market Size by Type 7.4 China Chronic Obstructive Pulmonary Disorder Market Size by Application 8 Japan 8.1 Japan Chronic Obstructive Pulmonary Disorder Market Size (2014-2019) 8.2 Chronic Obstructive Pulmonary Disorder Key Players in Japan 8.3 Japan Chronic Obstructive Pulmonary Disorder Market Size by Type 8.4 Japan Chronic Obstructive Pulmonary Disorder Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size (2014-2019) 9.2 Chronic Obstructive Pulmonary Disorder Key Players in Southeast Asia 9.3 Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size by Type 9.4 Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size by Application 10 India 10.1 India Chronic Obstructive Pulmonary Disorder Market Size (2014-2019) 10.2 Chronic Obstructive Pulmonary Disorder Key Players in India 10.3 India Chronic Obstructive Pulmonary Disorder Market Size by Type 10.4 India Chronic Obstructive Pulmonary Disorder Market Size by Application 11 Central & South America 11.1 Central & South America Chronic Obstructive Pulmonary Disorder Market Size (2014-2019) 11.2 Chronic Obstructive Pulmonary Disorder Key Players in Central & South America 11.3 Central & South America Chronic Obstructive Pulmonary Disorder Market Size by Type 11.4 Central & South America Chronic Obstructive Pulmonary Disorder Market Size by Application 12 International Players Profiles 12.1 GSK 12.1.1 GSK Company Details 12.1.2 Company Description and Business Overview 12.1.3 Chronic Obstructive Pulmonary Disorder Introduction 12.1.4 GSK Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019) 12.1.5 GSK Recent Development 12.2 Pfizer 12.2.1 Pfizer Company Details 12.2.2 Company Description and Business Overview 12.2.3 Chronic Obstructive Pulmonary Disorder Introduction 12.2.4 Pfizer Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019) 12.2.5 Pfizer Recent Development 12.3 Merck 12.3.1 Merck Company Details 12.3.2 Company Description and Business Overview 12.3.3 Chronic Obstructive Pulmonary Disorder Introduction 12.3.4 Merck Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019) 12.3.5 Merck Recent Development 12.4 Novartis 12.4.1 Novartis Company Details 12.4.2 Company Description and Business Overview 12.4.3 Chronic Obstructive Pulmonary Disorder Introduction 12.4.4 Novartis Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019) 12.4.5 Novartis Recent Development 12.5 AstraZeneca 12.5.1 AstraZeneca Company Details 12.5.2 Company Description and Business Overview 12.5.3 Chronic Obstructive Pulmonary Disorder Introduction 12.5.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019) 12.5.5 AstraZeneca Recent Development 12.6 Boehringer Ingelheim 12.6.1 Boehringer Ingelheim Company Details 12.6.2 Company Description and Business Overview 12.6.3 Chronic Obstructive Pulmonary Disorder Introduction 12.6.4 Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019) 12.6.5 Boehringer Ingelheim Recent Development 12.7 Teva Pharmaceuticals 12.7.1 Teva Pharmaceuticals Company Details 12.7.2 Company Description and Business Overview 12.7.3 Chronic Obstructive Pulmonary Disorder Introduction 12.7.4 Teva Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019) 12.7.5 Teva Pharmaceuticals Recent Development 12.8 Ario Pharma 12.8.1 Ario Pharma Company Details 12.8.2 Company Description and Business Overview 12.8.3 Chronic Obstructive Pulmonary Disorder Introduction 12.8.4 Ario Pharma Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019) 12.8.5 Ario Pharma Recent Development 12.9 Roche 12.9.1 Roche Company Details 12.9.2 Company Description and Business Overview 12.9.3 Chronic Obstructive Pulmonary Disorder Introduction 12.9.4 Roche Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019) 12.9.5 Roche Recent Development 12.10 Ache 12.10.1 Ache Company Details 12.10.2 Company Description and Business Overview 12.10.3 Chronic Obstructive Pulmonary Disorder Introduction 12.10.4 Ache Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019) 12.10.5 Ache Recent Development 12.11 Almirall 12.12 Aquinox Pharmaceuticals 12.13 Asmacure 12.14 Astellas Pharma 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Chronic Obstructive Pulmonary Disorder Key Market Segments Table Key Players Chronic Obstructive Pulmonary Disorder Covered Table Global Chronic Obstructive Pulmonary Disorder Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Chronic Obstructive Pulmonary Disorder Market Size Market Share by Type 2014-2025 Figure Short-Acting Bronchodilators Figures Table Key Players of Short-Acting Bronchodilators Figure Corticosteroids Figures Table Key Players of Corticosteroids Figure Methylxanthines Figures Table Key Players of Methylxanthines Figure Long-Acting Bronchodilators Figures Table Key Players of Long-Acting Bronchodilators Figure Phosphodiesterase-4 Inhibitors Figures Table Key Players of Phosphodiesterase-4 Inhibitors Figure Others Figures Table Key Players of Others Table Global Chronic Obstructive Pulmonary Disorder Market Size Growth by Application 2014-2025 (Million US$) Figure Hospitals Case Studies Figure Clinics Case Studies Figure Others Case Studies Figure Chronic Obstructive Pulmonary Disorder Report Years Considered Table Global Chronic Obstructive Pulmonary Disorder Market Size 2014-2025 (Million US$) Figure Global Chronic Obstructive Pulmonary Disorder Market Size and Growth Rate 2014-2025 (Million US$) Table Global Chronic Obstructive Pulmonary Disorder Market Size by Regions 2014-2025 (Million US$) Table Global Chronic Obstructive Pulmonary Disorder Market Size by Regions 2014-2019 (Million US$) Table Global Chronic Obstructive Pulmonary Disorder Market Share by Regions 2014-2019 Figure Global Chronic Obstructive Pulmonary Disorder Market Share by Regions 2014-2019 Figure Global Chronic Obstructive Pulmonary Disorder Market Share by Regions 2019 Table Market Top Trends Table Global Chronic Obstructive Pulmonary Disorder Revenue by Manufacturers (2014-2019) (Million US$) Table Global Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers (2014-2019) Figure Global Chronic Obstructive Pulmonary Disorder Market Share by Manufacturers in 2018 Table Global Chronic Obstructive Pulmonary Disorder Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Chronic Obstructive Pulmonary Disorder Product/Solution/Service Table Date of Enter into Chronic Obstructive Pulmonary Disorder Market Table Mergers & Acquisitions, Expansion Plans Table Global Chronic Obstructive Pulmonary Disorder Market Size by Type (2014-2019) (Million US$) Table Global Chronic Obstructive Pulmonary Disorder Market Size Share by Type (2014-2019) Figure Global Chronic Obstructive Pulmonary Disorder Market Size Market Share by Type (2014-2019) Table Global Chronic Obstructive Pulmonary Disorder Market Size by Application (2014-2019) (Million US$) Table Global Chronic Obstructive Pulmonary Disorder Market Size Share by Application (2014-2019) Figure Global Chronic Obstructive Pulmonary Disorder Market Size Market Share by Application (2014-2019) Figure Global Chronic Obstructive Pulmonary Disorder Revenue Market Share by Application in 2018 Figure United States Chronic Obstructive Pulmonary Disorder Market Size 2014-2019 (Million US$) Table United States Key Players Chronic Obstructive Pulmonary Disorder Revenue (2018-2019) (Million US$) Table United States Key Players Chronic Obstructive Pulmonary Disorder Market Share (2018-2019) Table United States Chronic Obstructive Pulmonary Disorder Market Size by Type (2014-2019) (Million US$) Table United States Chronic Obstructive Pulmonary Disorder Market Share by Type (2014-2019) Table United States Chronic Obstructive Pulmonary Disorder Market Size by Application (2014-2019) (Million US$) Table United States Chronic Obstructive Pulmonary Disorder Market Share by Application (2014-2019) Figure Europe Chronic Obstructive Pulmonary Disorder Market Size 2014-2019 (Million US$) Table Europe Key Players Chronic Obstructive Pulmonary Disorder Revenue (2018-2019) (Million US$) Table Europe Key Players Chronic Obstructive Pulmonary Disorder Market Share (2018-2019) Table Europe Chronic Obstructive Pulmonary Disorder Market Size by Type (2014-2019) (Million US$) Table Europe Chronic Obstructive Pulmonary Disorder Market Share by Type (2014-2019) Table Europe Chronic Obstructive Pulmonary Disorder Market Size by Application (2014-2019) (Million US$) Table Europe Chronic Obstructive Pulmonary Disorder Market Share by Application (2014-2019) Figure China Chronic Obstructive Pulmonary Disorder Market Size 2014-2019 (Million US$) Table China Key Players Chronic Obstructive Pulmonary Disorder Revenue (2018-2019) (Million US$) Table China Key Players Chronic Obstructive Pulmonary Disorder Market Share (2018-2019) Table China Chronic Obstructive Pulmonary Disorder Market Size by Type (2014-20189) (Million US$) Table China Chronic Obstructive Pulmonary Disorder Market Share by Type (2014-2019) Table China Chronic Obstructive Pulmonary Disorder Market Size by Application (2014-2019) (Million US$) Table China Chronic Obstructive Pulmonary Disorder Market Share by Application (2014-2019) Figure Japan Chronic Obstructive Pulmonary Disorder Market Size 2014-2019 (Million US$) Table Japan Key Players Chronic Obstructive Pulmonary Disorder Revenue (2018-2019) (Million US$) Table Japan Key Players Chronic Obstructive Pulmonary Disorder Market Share (2018-2019) Table Japan Chronic Obstructive Pulmonary Disorder Market Size by Type (2014-2019) (Million US$) Table Japan Chronic Obstructive Pulmonary Disorder Market Share by Type (2014-2019) Table Japan Chronic Obstructive Pulmonary Disorder Market Size by Application (2014-2019) (Million US$) Table Japan Chronic Obstructive Pulmonary Disorder Market Share by Application (2014-2019) Figure Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Chronic Obstructive Pulmonary Disorder Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Chronic Obstructive Pulmonary Disorder Market Share (2018-2019) Table Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Chronic Obstructive Pulmonary Disorder Market Share by Type (2014-2019) Table Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Chronic Obstructive Pulmonary Disorder Market Share by Application (2014-2019) Figure India Chronic Obstructive Pulmonary Disorder Market Size 2014-2019 (Million US$) Table India Key Players Chronic Obstructive Pulmonary Disorder Revenue (2018-2019) (Million US$) Table India Key Players Chronic Obstructive Pulmonary Disorder Market Share (2018-2019) Table India Chronic Obstructive Pulmonary Disorder Market Size by Type (2014-2019) (Million US$) Table India Chronic Obstructive Pulmonary Disorder Market Share by Type (2014-2019) Table India Chronic Obstructive Pulmonary Disorder Market Size by Application (2014-2019) (Million US$) Table India Chronic Obstructive Pulmonary Disorder Market Share by Application (2014-2019) Figure Central & South America Chronic Obstructive Pulmonary Disorder Market Size 2014-2019 (Million US$) Table Central & South America Key Players Chronic Obstructive Pulmonary Disorder Revenue (2018-2019) (Million US$) Table Central & South America Key Players Chronic Obstructive Pulmonary Disorder Market Share (2018-2019) Table Central & South America Chronic Obstructive Pulmonary Disorder Market Size by Type (2014-2019) (Million US$) Table Central & South America Chronic Obstructive Pulmonary Disorder Market Share by Type (2014-2019) Table Central & South America Chronic Obstructive Pulmonary Disorder Market Size by Application (2014-2019) (Million US$) Table Central & South America Chronic Obstructive Pulmonary Disorder Market Share by Application (2014-2019) Table GSK Company Details Table GSK Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019) (Million US$) Figure GSK Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2014-2019) Table GSK Recent Development Table Pfizer Company Details Table Pfizer Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)(Million US$) Figure Pfizer Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2014-2019) Table Pfizer Recent Development Table Merck Company Details Table Merck Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)(Million US$) Figure Merck Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2014-2019) Table Merck Recent Development Table Novartis Company Details Table Novartis Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)(Million US$) Figure Novartis Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2014-2019) Table Novartis Recent Development Table AstraZeneca Company Details Table AstraZeneca Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)(Million US$) Figure AstraZeneca Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2014-2019) Table AstraZeneca Recent Development Table Boehringer Ingelheim Company Details Table Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)(Million US$) Figure Boehringer Ingelheim Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2014-2019) Table Boehringer Ingelheim Recent Development Table Teva Pharmaceuticals Company Details Table Teva Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)(Million US$) Figure Teva Pharmaceuticals Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2014-2019) Table Teva Pharmaceuticals Recent Development Table Ario Pharma Company Details Table Ario Pharma Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)(Million US$) Figure Ario Pharma Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2014-2019) Table Ario Pharma Recent Development Table Roche Company Details Table Roche Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)(Million US$) Figure Roche Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2014-2019) Table Roche Recent Development Table Ache Company Details Table Ache Revenue in Chronic Obstructive Pulmonary Disorder Business (2014-2019)(Million US$) Figure Ache Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2014-2019) Table Ache Recent Development Table Almirall Company Details Table Aquinox Pharmaceuticals Company Details Table Asmacure Company Details Table Astellas Pharma Company Details Table Global Chronic Obstructive Pulmonary Disorder Market Size by Regions (Million US$) 2019-2025 Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Regions (2019-2025) Figure Global Chronic Obstructive Pulmonary Disorder Market Size Share by Regions in 2025 Figure United States Chronic Obstructive Pulmonary Disorder Market Size Forecast (2019-2025)(Million USD) Figure Europe Chronic Obstructive Pulmonary Disorder Market Size Forecast (2019-2025)(Million USD) Figure China Chronic Obstructive Pulmonary Disorder Market Size Forecast (2019-2025)(Million USD) Figure Japan Chronic Obstructive Pulmonary Disorder Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size Forecast (2019-2025)(Million USD) Figure India Chronic Obstructive Pulmonary Disorder Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Chronic Obstructive Pulmonary Disorder Market Size Forecast (2019-2025)(Million USD) Table Global Chronic Obstructive Pulmonary Disorder Market Size by Product (2019-2025) (Million US$) Figure Global Chronic Obstructive Pulmonary Disorder Market Size by Product (2019-2025) Figure Global Chronic Obstructive Pulmonary Disorder Market Size by Product in 2025 Table Global Chronic Obstructive Pulmonary Disorder Market Size by Application (2019-2025) (Million US$) Figure Global Chronic Obstructive Pulmonary Disorder Market Size by Application (2019-2025) Figure Global Chronic Obstructive Pulmonary Disorder Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

GSK Pfizer Merck Novartis AstraZeneca Boehringer Ingelheim Teva Pharmaceuticals Ario Pharma Roche Ache Almirall Aquinox Pharmaceuticals Asmacure Astellas Pharma